Staar Surgical Company (STAA)
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
STAAR Surgical Company (NASDAQ:STAA ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Brian Moore - VP, IR Tom Frinzi - Chair, President and CEO Patrick Williams - CFO Conference Call Participants Tom Stephan - Stifel Ryan Zimmerman - BTIG Patrick Wood - Morgan Stanley Operator Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, October 30th, 2024.
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
Staar Surgical (STAA) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.30 per share a year ago.
Here's Why Staar Surgical (STAA) Could be Great Choice for a Bottom Fisher
Staar Surgical (STAA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Fast Money traders share their favorite stocks of the week
Fast Money traders Steve Grasso, Tim Seymour, Julie Biel, and Mike Khouw share their favorite stocks from this week and explain the reasoning behind their choices.
Wall Street Analysts Predict a 43.93% Upside in Staar Surgical (STAA): Here's What You Should Know
The mean of analysts' price targets for Staar Surgical (STAA) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Staar Surgical (STAA) Moves to Buy: Rationale Behind the Upgrade
Staar Surgical (STAA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize
STAAR Surgical shares are down more than 15% since Q2 earnings, despite management raising full-year revenue guidance. Investments in the US market appear to be yielding promising results, as sales were up 25% year over year. According to my estimates, the company is on track to meet the low end of its 2026 financial targets.
Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
STAAR Surgical Company (STAA) Q2 2024 Earnings Call Transcript
STAAR Surgical Company (NASDAQ:STAA ) Q2 2024 Earnings Conference Call August 7, 2024 4:15 PM ET Company Participants Brian Moore – Vice President of Investor Relations Tom Frinzi - Chair of the Board, President & Chief Executive Officer Patrick Williams - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Tom Stephan - Stifel Margaret Kaczor Andrew - William Blair David Saxon - Needham Anthony Petrone - Mizuho George Sellers - Stephens John Young - Canaccord Operator Greetings and welcome to the STAAR Surgical Second Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, August 7, 2024.
Staar Surgical (STAA) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Staar Surgical (STAA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates
Staar Surgical (STAA) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.40 per share a year ago.
Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?
Staar Surgical (STAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
